Chest pain units.: Organization and protocol for the diagnosis of acute coronary syndromes

被引:67
作者
Fernández, JB
Ezquerra, EA
Genover, XB
O'Callaghan, AC
Gárriz, II
Nácher, JJJ
de Torres, FM
Romero, GS
机构
[1] Univ Navarra Clin, Dept Cardiol & Cirurgia Cardiovasc, Pamplona, Spain
[2] Hosp Clin Barcelona, Inst Enfermedades Cardiovasc, Barcelona, Spain
[3] Hosp La Fe, Unidad Coronaria, E-46009 Valencia, Spain
[4] Hosp Carlos Haya, Serv Cardiol, Malaga, Spain
[5] Hosp Alcorcon, Serv Cardiol, Madrid, Spain
[6] Hosp Leon, Serv Cardiol, Leon 24071, Spain
来源
REVISTA ESPANOLA DE CARDIOLOGIA | 2002年 / 55卷 / 02期
关键词
unstable angina; diagnosis; chest pain; coronary artery disease; myocardial infarction; emergency room;
D O I
10.1016/S0300-8932(02)76574-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The two main goals of chest pain units are the early, accurate diagnosis of acute coronary syndromes and the rapid, efficient recognition of low-risk patients who do not need hospital admission. Many clinical, practical, and economic reasons support the establishment of such units. Patients with chest pain account for a substantial proportion of emergency room turnover and their care is still far from optimal: 8% of patients sent home are later diagnosed of acute coronary syndrome and 60% of admissions for chest pain eventually prove to have been unnecessary. We present a systematic approach to create and manage a chest pain unit employing specialists headed by a cardiologist. The unit may be functional or located in a separate area of the emergency room. Initial triage is based on the clinical characteristics, the ECG and biomarkers of myocardial infarct. Risk stratification in the second phase selects patients to be admitted to the chest pain unit for 6-12 h. Finally, we propose treadmill testing before discharge to rule out the presence of acute myocardial ischemia or damage in patients with negative biomarkers and non-diagnostic serial ECGs.
引用
收藏
页码:143 / 154
页数:12
相关论文
共 49 条
[1]   Importance of posterior chest leads in patients with suspected myocardial infarction, but nondiagnostic, routine 12-lead electrocardiogram [J].
Agarwal, JB ;
Khaw, K ;
Aurignac, F ;
LoCurto, A .
AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (03) :323-326
[2]  
Aguayo de Hoyos E, 2001, Aten Primaria, V27, P478
[3]   Myocardial infarction redefined -: A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction [J].
Alpert, JS ;
Antman, E ;
Apple, F ;
Armstrong, PW ;
Bassand, JP ;
de Luna, AB ;
Beller, G ;
Breithardt, G ;
Chaitman, BR ;
Clemmensen, P ;
Falk, E ;
Fishbein, MC ;
Galvani, M ;
Garson, A ;
Grines, C ;
Hamm, C ;
Hoppe, U ;
Jaffe, A ;
Katus, H ;
Kjekshus, J ;
Klein, W ;
Klootwijk, P ;
Lenfant, C ;
Levy, D ;
Levy, RI ;
Luepker, R ;
Marcus, F ;
Näslund, U ;
Ohman, M ;
Pahlm, O ;
Poole-Wilson, P ;
Popp, R ;
Pyörälä, K ;
Ravkilde, J ;
Rehnquist, N ;
Roberts, W ;
Roberts, R ;
Roelandt, J ;
Rydén, L ;
Sans, S ;
Simoons, ML ;
Thygesen, K ;
Tunstall-Pedoe, H ;
Underwood, R ;
Uretsky, BF ;
de Werf, FV ;
Voipio-Pulkki, LM ;
Wagner, G ;
Wallentin, L ;
Wijns, W .
EUROPEAN HEART JOURNAL, 2000, 21 (18) :1502-1513
[4]   COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].
ALTMAN, R ;
CARRERAS, L ;
DIAZ, R ;
FIGUEROA, E ;
PAOLASSO, E ;
PARODI, JC ;
CADE, JF ;
DONNAN, G ;
EADIE, MJ ;
GAVAGHAN, TP ;
OSULLIVAN, EF ;
PARKIN, D ;
RENNY, JTG ;
SILAGY, C ;
VINAZZER, H ;
ZEKERT, F ;
ADRIAENSEN, H ;
BERTRANDHARDY, JM ;
BRAN, M ;
DAVID, JL ;
DRICOT, J ;
LAVENNEPARDONGE, E ;
LIMET, R ;
LOWENTHAL, A ;
MORIAU, M ;
SCHAPIRA, S ;
SMETS, P ;
SYMOENS, J ;
VERHAEGHE, R ;
VERSTRAETE, M ;
ATALLAH, A ;
BARNETT, H ;
BATISTA, R ;
BLAKELY, J ;
CAIRNS, JA ;
COTE, R ;
CROUCH, J ;
EVANS, G ;
FINDLAY, JM ;
GENT, M ;
LANGLOIS, Y ;
LECLERC, J ;
NORRIS, J ;
PINEO, GF ;
POWERS, PJ ;
ROBERTS, R ;
SCHWARTZ, L ;
SICURELLA, J ;
TAYLOR, W ;
THEROUX, P .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100
[5]  
*AM COLL EM PHYS, 1999, ANN EMERG MED, V33, P372
[6]  
[Anonymous], 1997, Eur Heart J, V18, P1569
[7]   INDICATIONS FOR FIBRINOLYTIC THERAPY IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION - COLLABORATIVE OVERVIEW OF EARLY MORTALITY AND MAJOR MORBIDITY RESULTS FROM ALL RANDOMIZED TRIALS OF MORE THAN 1000 PATIENTS [J].
APPLEBY, P ;
BAIGENT, C ;
COLLINS, R ;
FLATHER, M ;
PARISH, S ;
PETO, R ;
BELL, P ;
HALLS, H ;
MEAD, G ;
DIAZ, R ;
PAOLASSO, E ;
PAVIOTTI, C ;
ROMERO, G ;
CAMPBELL, T ;
OROURKE, MF ;
THOMPSON, P ;
LESAFFRE, E ;
VANDEWERF, F ;
VERSTRAETE, M ;
ARMSTRONG, PW ;
CAIRNS, JA ;
MORAN, C ;
TURPIE, AG ;
YUSUF, S ;
GRANDE, P ;
HEIKKILA, J ;
KALA, R ;
BASSAND, JP ;
BOISSEL, JP ;
BROCHIER, M ;
LEIZOROVICZ, A ;
BRUGGEMANN, T ;
KARSCH, KR ;
KASPER, W ;
LAMMERTS, D ;
NEUHAUS, KL ;
MEYER, J ;
SCHRODER, R ;
VONESSEN, R ;
SARAN, RK ;
ARDISSINO, D ;
BONADUCE, D ;
BRUNELLI, C ;
CERNIGLIARO, C ;
FORESTI, A ;
FRANZOSI, MG ;
GUIDUCCI, D ;
MAGGIONI, A ;
MAGNANI, B ;
MATTIOLI, G .
LANCET, 1994, 343 (8893) :311-322
[8]   Guidelines of the Spanish society of cardiology in acute myocardial infarction [J].
Arós, F ;
Loma-Osorio, A ;
Alonso, A ;
Alonso, JJ ;
Cabadés, A ;
Coma-Canella, I ;
García-Castrillo, L ;
García, E ;
de Sá, EL ;
Pabón, P ;
San José, JM ;
Vera, A ;
Worner, F .
REVISTA ESPANOLA DE CARDIOLOGIA, 1999, 52 (11) :919-956
[9]  
Arós F, 1999, REV ESP CARDIOL, V52, P39
[10]   Guidelines of the Spanish Society of Cardiology for clinical practice in exercise testing [J].
Arós, F ;
Boraita, A ;
Alegría, E ;
Alonso, AM ;
Bardají, A ;
Lamiel, R ;
Luengo, E ;
Rabadán, M ;
Alijarde, M ;
Aznar, J ;
Baño, A ;
Cabañero, M ;
Calderón, C ;
Camprubí, M ;
Candell, J ;
Crespo, M ;
de la Morena, G ;
Fernández, A ;
Ferrero, JA ;
Gayán, R ;
Bolao, IG ;
Hernández, M ;
Maceira, A ;
Marín, E ;
de Lara, AM ;
Placer, L ;
San Román, JAS ;
Serratosa, L ;
Sosa, V ;
Subirana, MT ;
Wilke, M .
REVISTA ESPANOLA DE CARDIOLOGIA, 2000, 53 (08) :1063-1094